世界の止血診断市場は、2022年に約641万米ドルと評価され、予測期間の2023年から2030年には8.60%以上の健全な成長率で成長すると予測されています。止血診断装置は、過剰な出血を引き起こす止血障害の発見に役立ちます。止血中、血液は液体からゲル状に変化します。止血は、損傷後に失血を制限し、血流を止めるために身体が使用する技術です。これに続いて、血管収縮、血小板栓形成、血液凝固という 3 つのステップがさらに行われます。患者、特に処置後に体内から余分な血液を失いやすい患者の血液凝固診断率の上昇が、市場拡大を推進する重要な理由となっています。がん、糖尿病、神経疾患など多くの疾患の罹患率の増加、高齢者人口の増加、ライフスタイルの変化が止血診断市場を牽引しています。予測期間中、世界の止血診断市場は血友病有病率の増加によって牽引されると予想されます。
血液凝固障害の発生件数の増加、医療における技術開発、自動止血装置の受け入れ拡大などが、検討中の市場の成長に影響を及ぼしています。World Bleeding Disorders Registry 2021の報告書によると、37カ国の調査で2021年12月時点で血友病患者は9,414人と報告されており、罹患者数では東南アジアが2,828人と最も多く、次いで東地中海が2,418人、アフリカが1,027人となっています。さらに、分子診断検査や専門的診断検査を小型化するための研究開発の継続的な進展は、予測期間中に市場に有利な機会を創出すると予想されます。しかし、新興国市場では、厳しい政府規制に加えて、止血疾患に対する認識不足が、2023年から2030年の予測期間を通じて市場成長の妨げになる可能性があります。
世界の止血診断市場調査の対象となる主要地域には、アジア太平洋、北アメリカ、ヨーロッパ、ラテンアメリカ、中東およびアフリカが含まれます。北アメリカは、強力な自動分析装置の普及、大規模な患者プールの利用可能性、血栓症の頻度の高さ、政府の支持的な取り組みにより、2022年の市場を独占しました。アジア太平洋地域は予測期間中に大きく成長すると予想され、この地域の市場急拡大は、医療インフラの改善を目的としたいくつかの政府の取り組みに起因しています。同地域の市場は他の地域と比較して大きく成長すると予想されますが、これは製薬ビジネスや臨床研究産業の基盤が先進国から中国やインドなどの新興国へと変化しているためです。
この調査の目的は、近年のさまざまなセグメントおよび国の市場規模を定義し、今後数年間の市場規模を予測することです。この報告書は、調査に参加している国の業界の定性的および定量的側面の両方を組み込むように設計されています。
このレポートは、市場の将来の成長を定義する推進要因や課題などの重要な側面に関する詳細情報も提供します。さらに、競争環境と主要企業の製品提供の詳細な分析とともに、利害関係者が投資できるミクロ市場における潜在的な機会も組み込まれています。
目次
Table of Contents
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Million)
1.2.1. Hemostasis Diagnostics Market, by Region, 2020-2030 (USD Million)
1.2.2. Hemostasis Diagnostics Market, by Product, 2020-2030 (USD Million)
1.2.3. Hemostasis Diagnostics Market, by Test Type, 2020-2030 (USD Million)
1.2.4. Hemostasis Diagnostics Market, by End Use, 2020-2030 (USD Million)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Hemostasis Diagnostics Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Hemostasis Diagnostics Market Dynamics
3.1. Hemostasis Diagnostics Market Impact Analysis (2020-2030)
3.1.1. Market Drivers
3.1.1.1. Rising Incidences of Blood Clotting Disorders
3.1.1.2. Rising Adoption of Automated Hemostasis Equipment
3.1.2. Market Challenges
3.1.2.1. Stringent Government Regulation
3.1.3. Market Opportunities
3.1.3.1. Advancements in R&D
Chapter 4. Global Hemostasis Diagnostics Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter's 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
Chapter 5. Global Hemostasis Diagnostics Market, by Product
5.1. Market Snapshot
5.2. Global Hemostasis Diagnostics Market by Product, Performance - Potential Analysis
5.3. Global Hemostasis Diagnostics Market Estimates & Forecasts by Product 2020-2030 (USD Million)
5.4. Hemostasis Diagnostics Market, Sub Segment Analysis
5.4.1. Laboratory Analyzers
5.4.2. Point-of-Care Testing Systems
Chapter 6. Global Hemostasis Diagnostics Market, by Test Type
6.1. Market Snapshot
6.2. Global Hemostasis Diagnostics Market by Test Type, Performance - Potential Analysis
6.3. Global Hemostasis Diagnostics Market Estimates & Forecasts by Test Type 2020-2030 (USD Million)
6.4. Hemostasis Diagnostics Market, Sub Segment Analysis
6.4.1. Activated Partial Thromboplastin Time
6.4.2. D Dimer Test
6.4.3. Fibrinogen Test
6.4.4. Prothrombin Time Test
6.4.5. Activated Clotting Time
6.4.6. Platelet Aggregation Test
Chapter 7. Global Hemostasis Diagnostics Market, by End Use
7.1. Market Snapshot
7.2. Global Hemostasis Diagnostics Market by End Use, Performance - Potential Analysis
7.3. Global Hemostasis Diagnostics Market Estimates & Forecasts by End Use 2020-2030 (USD Million)
7.4. Hemostasis Diagnostics Market, Sub Segment Analysis
7.4.1. Hospitals
7.4.2. Diagnostic Centers
7.4.3. Others
Chapter 8. Global Hemostasis Diagnostics Market, Regional Analysis
8.1. Top Leading Countries
8.2. Top Emerging Countries
8.3. Hemostasis Diagnostics Market, Regional Market Snapshot
8.4. North America Hemostasis Diagnostics Market
8.4.1. U.S. Hemostasis Diagnostics Market
8.4.1.1. Product breakdown estimates & forecasts, 2020-2030
8.4.1.2. Test Type breakdown estimates & forecasts, 2020-2030
8.4.1.3. End Use breakdown estimates & forecasts, 2020-2030
8.4.2. Canada Hemostasis Diagnostics Market
8.5. Europe Hemostasis Diagnostics Market Snapshot
8.5.1. U.K. Hemostasis Diagnostics Market
8.5.2. Germany Hemostasis Diagnostics Market
8.5.3. France Hemostasis Diagnostics Market
8.5.4. Spain Hemostasis Diagnostics Market
8.5.5. Italy Hemostasis Diagnostics Market
8.5.6. Rest of Europe Hemostasis Diagnostics Market
8.6. Asia-Pacific Hemostasis Diagnostics Market Snapshot
8.6.1. China Hemostasis Diagnostics Market
8.6.2. India Hemostasis Diagnostics Market
8.6.3. Japan Hemostasis Diagnostics Market
8.6.4. Australia Hemostasis Diagnostics Market
8.6.5. South Korea Hemostasis Diagnostics Market
8.6.6. Rest of Asia Pacific Hemostasis Diagnostics Market
8.7. Latin America Hemostasis Diagnostics Market Snapshot
8.7.1. Brazil Hemostasis Diagnostics Market
8.7.2. Mexico Hemostasis Diagnostics Market
8.8. Middle East & Africa Hemostasis Diagnostics Market
8.8.1. Saudi Arabia Hemostasis Diagnostics Market
8.8.2. South Africa Hemostasis Diagnostics Market
8.8.3. Rest of Middle East & Africa Hemostasis Diagnostics Market
Chapter 9. Competitive Intelligence
9.1. Key Company SWOT Analysis
9.1.1. Company 1
9.1.2. Company 2
9.1.3. Company 3
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. Abbott
9.3.1.1. Key Information
9.3.1.2. Overview
9.3.1.3. Financial (Subject to Data Availability)
9.3.1.4. Product Summary
9.3.1.5. Recent Developments
9.3.2. Thermo Fisher Scientific Inc.
9.3.3. HORIBA Europe Holding
9.3.4. Medtronic
9.3.5. Technidyne Corporation
9.3.6. Grifols S.A
9.3.7. F. Hoffmann-La Roche Ltd.
9.3.8. NIHON KOHDEN CORPORATION
9.3.9. Haemonetics Corporation
9.3.10. Beckman Coulter Inc.
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption
LIST OF TABLES
TABLE 1. Global Hemostasis Diagnostics Market, report scope
TABLE 2. Global Hemostasis Diagnostics Market estimates & forecasts by Region 2020-2030 (USD Million)
TABLE 3. Global Hemostasis Diagnostics Market estimates & forecasts by Product 2020-2030 (USD Million)
TABLE 4. Global Hemostasis Diagnostics Market estimates & forecasts by Test Type 2020-2030 (USD Million)
TABLE 5. Global Hemostasis Diagnostics Market estimates & forecasts by End Use 2020-2030 (USD Million)
TABLE 6. Global Hemostasis Diagnostics Market by segment, estimates & forecasts, 2020-2030 (USD Million)
TABLE 7. Global Hemostasis Diagnostics Market by region, estimates & forecasts, 2020-2030 (USD Million)
TABLE 8. Global Hemostasis Diagnostics Market by segment, estimates & forecasts, 2020-2030 (USD Million)
TABLE 9. Global Hemostasis Diagnostics Market by region, estimates & forecasts, 2020-2030 (USD Million)
TABLE 10. Global Hemostasis Diagnostics Market by segment, estimates & forecasts, 2020-2030 (USD Million)
TABLE 11. Global Hemostasis Diagnostics Market by region, estimates & forecasts, 2020-2030 (USD Million)
TABLE 12. Global Hemostasis Diagnostics Market by segment, estimates & forecasts, 2020-2030 (USD Million)
TABLE 13. Global Hemostasis Diagnostics Market by region, estimates & forecasts, 2020-2030 (USD Million)
TABLE 14. Global Hemostasis Diagnostics Market by segment, estimates & forecasts, 2020-2030 (USD Million)
TABLE 15. Global Hemostasis Diagnostics Market by region, estimates & forecasts, 2020-2030 (USD Million)
TABLE 16. U.S. Hemostasis Diagnostics Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 17. U.S. Hemostasis Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 18. U.S. Hemostasis Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 19. Canada Hemostasis Diagnostics Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 20. Canada Hemostasis Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 21. Canada Hemostasis Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 22. UK Hemostasis Diagnostics Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 23. UK Hemostasis Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 24. UK Hemostasis Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 25. Germany Hemostasis Diagnostics Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 26. Germany Hemostasis Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 27. Germany Hemostasis Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 28. France Hemostasis Diagnostics Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 29. France Hemostasis Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 30. France Hemostasis Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 31. Italy Hemostasis Diagnostics Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 32. Italy Hemostasis Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 33. Italy Hemostasis Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 34. Spain Hemostasis Diagnostics Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 35. Spain Hemostasis Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 36. Spain Hemostasis Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 37. RoE Hemostasis Diagnostics Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 38. RoE Hemostasis Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 39. RoE Hemostasis Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 40. China Hemostasis Diagnostics Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 41. China Hemostasis Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 42. China Hemostasis Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 43. India Hemostasis Diagnostics Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 44. India Hemostasis Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 45. India Hemostasis Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 46. Japan Hemostasis Diagnostics Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 47. Japan Hemostasis Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 48. Japan Hemostasis Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 49. South Korea Hemostasis Diagnostics Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 50. South Korea Hemostasis Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 51. South Korea Hemostasis Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 52. Australia Hemostasis Diagnostics Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 53. Australia Hemostasis Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 54. Australia Hemostasis Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 55. RoAPAC Hemostasis Diagnostics Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 56. RoAPAC Hemostasis Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 57. RoAPAC Hemostasis Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 58. Brazil Hemostasis Diagnostics Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 59. Brazil Hemostasis Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 60. Brazil Hemostasis Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 61. Mexico Hemostasis Diagnostics Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 62. Mexico Hemostasis Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 63. Mexico Hemostasis Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 64. RoLA Hemostasis Diagnostics Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 65. RoLA Hemostasis Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 66. RoLA Hemostasis Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 67. Saudi Arabia Hemostasis Diagnostics Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 68. South Africa Hemostasis Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 69. RoMEA Hemostasis Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 70. List of secondary sources, used in the study of global Hemostasis Diagnostics Market
TABLE 71. List of primary sources, used in the study of global Hemostasis Diagnostics Market
TABLE 72. Years considered for the study
TABLE 73. Exchange rates considered
List of tables and figures are dummy in nature, final lists may vary in the final deliverable
LIST OF FIGURES
FIG 1. Global Hemostasis Diagnostics Market, research methodology
FIG 2. Global Hemostasis Diagnostics Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Hemostasis Diagnostics Market, key trends 2022
FIG 5. Global Hemostasis Diagnostics Market, growth prospects 2023-2030
FIG 6. Global Hemostasis Diagnostics Market, porters 5 force model
FIG 7. Global Hemostasis Diagnostics Market, pest analysis
FIG 8. Global Hemostasis Diagnostics Market, value chain analysis
FIG 9. Global Hemostasis Diagnostics Market by segment, 2020 & 2030 (USD Million)
FIG 10. Global Hemostasis Diagnostics Market by segment, 2020 & 2030 (USD Million)
FIG 11. Global Hemostasis Diagnostics Market by segment, 2020 & 2030 (USD Million)
FIG 12. Global Hemostasis Diagnostics Market by segment, 2020 & 2030 (USD Million)
FIG 13. Global Hemostasis Diagnostics Market by segment, 2020 & 2030 (USD Million)
FIG 14. Global Hemostasis Diagnostics Market, regional snapshot 2020 & 2030
FIG 15. North America Hemostasis Diagnostics Market 2020 & 2030 (USD Million)
FIG 16. Europe Hemostasis Diagnostics Market 2020 & 2030 (USD Million)
FIG 17. Asia pacific Hemostasis Diagnostics Market 2020 & 2030 (USD Million)
FIG 18. Latin America Hemostasis Diagnostics Market 2020 & 2030 (USD Million)
FIG 19. Middle East & Africa Hemostasis Diagnostics Market 2020 & 2030 (USD Million)
List of tables and figures are dummy in nature, final lists may vary in the final deliverable
